News & Updates
Press releases & announcements.
The latest news from GutRecover Therapeutics — milestones, publications, partnerships, and scientific updates.
Press Releases
Recent announcements
May 12, 2026
Press Release
GutRecover Therapeutics announces enrolment of first patient in Phase 1 RESTORe-101 study — placeholder headline
GutRecover Therapeutics LLC today announced the enrolment of the first patient in its Phase 1 clinical study evaluating GR-101 for the prevention of recurrent gastrointestinal infection. Placeholder body copy — replace with actual press release text.
Mar 4, 2026
Publication
GutRecover scientists publish preclinical data for GR-101 in leading microbiome journal — placeholder headline
Peer-reviewed data demonstrating efficacy of GR-101 consortium in a validated gnotobiotic model of post-infectious dysbiosis. Placeholder — replace with actual publication details.
Jan 20, 2026
In the Media
GutRecover Therapeutics featured in coverage of next-generation microbiome therapeutics — placeholder headline
Placeholder — replace with actual media coverage summary and link to original article.
Nov 8, 2025
Press Release
GutRecover Therapeutics completes IND-enabling studies for GR-101 lead program — placeholder headline
Placeholder — replace with actual press release text.
Sep 3, 2025
Press Release
QADR Biotechnology announces establishment of GutRecover Therapeutics LLC in Delaware — placeholder headline
Placeholder — replace with actual press release text describing the company formation and initial financing.